Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
TriMas Co. (NASDAQ:TRS - Get Rating) insider John Philip Schaefer sold 6,800 shares of the firm's stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $29.91, for a total value of $203,388.00. Following the completion of the transaction, the insider now owns 11,087 shares of the company's stock, valued at approximately $331,612.17. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Shares of NASDAQ TRS traded up $0.07 during trading on Thursday, reaching $28.96. 91,232 shares of the company traded hands, compared to its average volume of 111,223. The firm's fifty day simple moving average is $29.62 and its 200 day simple moving average is $32.33. The stock has a market cap of $1.23 billion, a P/E ratio of 21.50 and a beta of 0.74. TriMas Co. has a 12-month low of $26.06 and a 12-month high of $38.72. The company has a current ratio of 2.48, a quick ratio of 1.46 and a debt-to-equity ratio of 0.62.
TriMas (NASDAQ:TRS - Get Rating) last released its quarterly earnings data on Thursday, April 28th. The industrial products company reported $0.50 earnings per share for the quarter, meeting analysts' consensus estimates of $0.50. The business had revenue of $224.30 million during the quarter, compared to analyst estimates of $233.68 million. TriMas had a return on equity of 13.05% and a net margin of 6.68%. The company's revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the business posted $0.40 EPS. As a group, research analysts expect that TriMas Co. will post 2.28 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 12th. Stockholders of record on Thursday, May 5th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date was Wednesday, May 4th. TriMas's dividend payout ratio (DPR) is presently 11.85%.
Large investors have recently bought and sold shares of the company. Charles Schwab Investment Management Inc. grew its position in shares of TriMas by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 429,571 shares of the industrial products company's stock valued at $15,895,000 after acquiring an additional 7,379 shares during the period. Riverwater Partners LLC acquired a new stake in shares of TriMas during the 4th quarter valued at about $304,000. Wilen Investment Management CORP. acquired a new stake in shares of TriMas during the 3rd quarter valued at about $177,000. Yarbrough Capital LLC acquired a new stake in shares of TriMas during the 4th quarter valued at about $402,000. Finally, Credit Suisse AG grew its position in shares of TriMas by 16.8% during the 3rd quarter. Credit Suisse AG now owns 35,371 shares of the industrial products company's stock valued at $1,146,000 after acquiring an additional 5,078 shares during the period.
A number of equities analysts recently issued reports on TRS shares. StockNews.com upgraded TriMas from a "hold" rating to a "buy" rating in a research note on Monday, April 11th. TheStreet lowered TriMas from a "b" rating to a "c+" rating in a research note on Monday, April 4th.
TriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands.
Read MoreGet a free copy of the StockNews.com research report on TriMas (TRS)The Institutions Are Rotating Into Olli’s Bargain Outlet Microcap Oil-Dri Corporation Is A Buy For Income InvestorsInflation, An Economic Winter Is Approaching Would Netflix acquiring Roku be a positive for the stock?Now’s The Time To Buy MongoDB (NASDAQ: MDB)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "N/A" rating among analysts, top-rated analysts believe these five stocks are better buys.
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Kate chats with financial advisor and asset manager Marc Scudillo, who discusses some psychological aspects of investing in the current market, as well as the benefits of specific asset classes and investing styles.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.